Seoulin Bioscience Company Limited operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Seoulin Bioscience Company Limited with three other
companies in this sector in South Korea:
Legochem Biosciences Inc
sales of 25.24 billion Korean Won [US$21.73 million]
of which 90%
was Medical development),
(25.80 billion Korean Won [US$22.21 million]
of which 54%
was Diagnosis), and
Medipost Co Ltd
(44.38 billion Korean Won [US$38.21 million]
of which 47%
was Umbilical Cord Blood).
During the year ended December of 2018, sales at
Seoulin Bioscience Company Limited were 49.88 billion Korean Won (US$42.94 million).
increase of 17.0%
versus 2017, when the company's sales were 42.62 billion Korean Won.